Información del producto
Nombre:BML-210
Marca:Biosynth
Descripción:BML-210 is a protein synthesis inhibitor that has been shown to have the ability to inhibit the proliferation of cancer cells. It inhibits cell cycle progression by modulating the activity of cyclin-dependent kinases. BML-210 also inhibits the production of nitric oxide, which is a key mediator in autoimmune diseases and other inflammatory disorders. BML-210 has been shown to be effective for treating cervical cancer, as well as cardiac and mouse hippocampal cancers. The drug also has an effect on DNA methyltransferase, which is an enzyme that controls gene expression and can inhibit tumor growth. In addition, BML-210 can be used to treat all types of cancer that are resistant to treatment with taxane drugs.
Aviso:Nuestros productos están destinados únicamente para uso en laboratorio. Para cualquier otro uso, por favor contáctenos.
Propiedades químicas
Peso molecular:339.43 g/mol
Fórmula:C20H25N3O2
Pureza:Min. 95%
Consulta técnica sobre: BML-210
Use el carrito para solicitar presupuestos o pedidos
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.